BIOMAT Database Logo BIOMAT Database Logo

Mass medication with aspirin and platelet aggregation. 1981

J C Krantz

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

J C Krantz
Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
January 2008, Cerebrovascular diseases (Basel, Switzerland),
J C Krantz
[Platelet aggregation, coronary insufficiency and aspirin].
March 1990, Arquivos brasileiros de cardiologia,
J C Krantz
Aspirin kinetics and platelet aggregation in man.
March 1983, Clinical pharmacology and therapeutics,
J C Krantz
Aspirin and other platelet-aggregation inhibiting drugs.
January 1985, The Medical journal of Australia,
J C Krantz
[Aspirin as treatment for platelet aggregation].
January 1975, Phlebologie,
J C Krantz
Platelet volume and aspirin-induced inhibition of aggregation.
October 1976, Blood,
J C Krantz
Effect of flurbiprofen and aspirin on platelet aggregation.
December 1991, Clinical pharmacy,
J C Krantz
Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81 mg.
April 2016, Journal of clinical pharmacology,
J C Krantz
Dose-dependent aspirin hydrolysis and platelet aggregation in patients with atherosclerosis.
February 1992, Journal of clinical pharmacology,
J C Krantz
Platelet aggregation in partially obstructed vessels and its elimination with aspirin.
September 1976, Circulation,
Copied contents to your clipboard!